» Articles » PMID: 30416405

Apoptotic Effect of Melittin Purified from Iranian Honey Bee Venom on Human Cervical Cancer HeLa Cell Line

Overview
Publisher Springer
Date 2018 Nov 13
PMID 30416405
Citations 27
Authors
Affiliations
Soon will be listed here.
Abstract

Melittin, an amphipathic 26-residue peptide, is the main component of honey bee venom. Studies have been demonstrated that melittin has an inhibitory effect on proliferation of cancer cells. However, the precise mechanism of action is not completely understood. In the present study we have shown that purified melittin from Iranian honey bee venom shows anti-cancer effects on human cervical cancer cell line through induction of apoptosis. The venom was collected from Iranian honey bee () and melittin isolated using reversed phase HPLC. Biological activity of melittin was analyzed by hemolytic test on human red blood cells. In order to investigate whether melittin inhibits proliferation of cervical cancer cells, the viability of the melittin treated HeLa cell line was measured via MTT assay. Finally, cell death analysis was performed using Propidum iodide and Annexin V-FITC dual staining. The results showed that the half hemolytic concentration (HD50) induced by mellitin was 0.5 µg/ml in free FBS solution. IC50 obtained after 12 h at 1.8 µg/ml by MTT assay. According to flow cytometric analysis, melittin induced apoptosis at concentrations more than 1 µg/ml. These results suggest that melittin induces apoptotic cell death in cervical cancerous cells as observed by flow cytometric assay. It is concluded that melittin could be regarded as a potential candidate in future studies to discovery of new anticancer agents.

Citing Articles

Low-dose Bee Venom as a Potential Therapeutic Agent Against Human Chronic Myeloid Leukaemia Cells.

Halici H, Un H, Celik S, Karakoy Z, Bayraktutan Z, Ozlu C Protein J. 2025; .

PMID: 39924635 DOI: 10.1007/s10930-025-10251-2.


Stem bark ethanolic extract of induces caspase 9-mediated apoptosis in HeLa cells.

Achmad A, Proboningrat A, Ansori A, Fadholly A, Rochmi S, Samsudin R Open Vet J. 2024; 14(10):2628-2633.

PMID: 39545198 PMC: 11560255. DOI: 10.5455/OVJ.2024.v14.i10.12.


Harnessing the power of bee venom for therapeutic and regenerative medical applications: an updated review.

Sadek K, Shib N, Taher E, Rashed F, Shukry M, Atia G Front Pharmacol. 2024; 15:1412245.

PMID: 39092234 PMC: 11291246. DOI: 10.3389/fphar.2024.1412245.


Synergistic Antibacterial Efficacy of Melittin in Combination with Oxacillin against Methicillin-Resistant (MRSA).

Pereira A, Sani A, Zapata T, Sousa D, Rossini B, Santos L Microorganisms. 2023; 11(12).

PMID: 38138012 PMC: 10745785. DOI: 10.3390/microorganisms11122868.


Melittin: a possible regulator of cancer proliferation in preclinical cell culture and animal models.

Haque S, Hussain A, Joshi H, Sharma U, Sharma B, Aggarwal D J Cancer Res Clin Oncol. 2023; 149(19):17709-17726.

PMID: 37919474 DOI: 10.1007/s00432-023-05458-8.


References
1.
Park M, Choi M, Kwak D, Oh K, Yoon D, Han S . Anti-cancer effect of bee venom in prostate cancer cells through activation of caspase pathway via inactivation of NF-κB. Prostate. 2011; 71(8):801-12. DOI: 10.1002/pros.21296. View

2.
Ghabili K, Shoja M, Parvizi M . Bee venom therapy: a probable etiology of aneurysm formation in aorta. Med Hypotheses. 2009; 73(3):459-60. DOI: 10.1016/j.mehy.2009.03.022. View

3.
Li B, Gu W, Zhang C, Huang X, Han K, Ling C . Growth arrest and apoptosis of the human hepatocellular carcinoma cell line BEL-7402 induced by melittin. Onkologie. 2006; 29(8-9):367-71. DOI: 10.1159/000094711. View

4.
Maher S, McClean S . Melittin exhibits necrotic cytotoxicity in gastrointestinal cells which is attenuated by cholesterol. Biochem Pharmacol. 2007; 75(5):1104-14. DOI: 10.1016/j.bcp.2007.10.029. View

5.
Rady I, Siddiqui I, Rady M, Mukhtar H . Melittin, a major peptide component of bee venom, and its conjugates in cancer therapy. Cancer Lett. 2017; 402:16-31. PMC: 5682937. DOI: 10.1016/j.canlet.2017.05.010. View